Role of glycosylation on the ensemble of conformations in the MUC1 immunodominant epitope

被引:2
|
作者
Singh, Jaideep [1 ]
Her, Cheenou [1 ]
Supekar, Nitin [2 ,3 ]
Boons, Geert-Jan [2 ,3 ,4 ,5 ]
Krishnan, Viswanathan V. [1 ,6 ]
Brooks, Cory L. [1 ]
机构
[1] Calif State Univ Fresno, Dept Chem, 2555 E San Ramon Ave, Fresno, CA 93740 USA
[2] Univ Georgia, Dept Chem, 140 Cedar St, Athens, GA 30602 USA
[3] Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA USA
[4] Univ Utrecht, Dept Chem Biol & Drug Discovery, Utrecht Inst Pharmaceut Sci, Univ Weg 99, NL-3584 CG Utrecht, Netherlands
[5] Univ Utrecht, Bijvoet Ctr Biomol Res, Univ Weg 99, NL-3584 CG Utrecht, Netherlands
[6] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Davis, CA 95616 USA
关键词
antibody-antigen; ensemble; glycobiology; immunotherapy; mucin; NMR; O-GLYCOSYLATION; MONOCLONAL-ANTIBODY; CANCER VACCINES; PHASE-I; PROTEIN; RECOGNITION; PEPTIDE; BINDING; TANDEM; ANTIGEN;
D O I
10.1002/psc.3229
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MUC1 is a membrane glycoprotein, which in adenocarninomas is overexpressed and exhibits truncated O-glycosylation. Overexpression and altered glycosylation make MUC1 into a candidate for immunotherapy. Monoclonal antibodies directed against MUC1 frequently bind an immunodominant epitope that contains a single site for O-glycosylation. Glycosylation with tumor carbohydrate antigens such as the Tn-antigen (GalNAc-O-Ser/Thr) results in antibodies binding with higher affinity. One proposed model to explain the enhanced affinity of antibodies for the glycosylated antigen is that the addition of a carbohydrate alters the conformational properties, favoring a binding-competent state. The conformational effects associated with Tn glycosylation of the MUC1 antigen was investigated using solution-state NMR and molecular dynamics. NMR experiments revealed distinct substructures of the glycosylated MUC1 peptides compared with the unglycosylated peptide. Molecular dynamics simulations of the MUC1 glycopeptide and peptide revealed distinguishing differences in their conformational preferences. Furthermore, the glycopeptide displayed a smaller conformational sampling compared with the peptide, suggesting that the glycopeptide sampled a narrower conformational space and is less dynamic. A comparison of the computed ensemble of conformations assuming random distribution, NMR models, and molecular dynamics simulations indicated that the MUC1 glycopeptide and aglycosylated peptide sampled structurally distinctly ensembles and that these ensembles were different from that of the random coil. Together, these data support the hypothesis that that conformational pre-selection could be an essential feature of these peptides that dictates the binding affinities to MUC1 specific antibodies.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] N-glycosylation of the MUC1 mucin in epithelial cells and secretions
    Parry, Simon
    Hanisch, Franz Georg
    Leir, Shih-Hsing
    Sutton-Smith, Mark
    Morris, Howard R.
    Dell, Anne
    Harris, Ann
    GLYCOBIOLOGY, 2006, 16 (07) : 623 - 634
  • [22] MUC1 expression and glycosylation status in cutaneous squamous cell carcinoma
    Cooper, HL
    Theaker, JM
    Mallipeddi, R
    McGrath, J
    Friedmann, P
    Healy, E
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (04) : 868 - 868
  • [23] Cancer cell resistance to anoikis: MUC1 glycosylation comes to play
    Yu, Lu-Gang
    CELL DEATH & DISEASE, 2017, 8 : e2962 - e2962
  • [24] Pseudomonas adhesion to MUC1 mucins:: A potential role of MUC1 mucins in clearance of inhaled bacteria
    Kim, KC
    Hyun, SW
    Kim, BT
    Meerzaman, D
    Lee, MK
    Lillehoj, E
    CILIA AND MUCUS: FROM DEVELOPMENT TO RESPIRATORY DEFENSE, 2001, : 217 - 224
  • [25] The Role of MUC1 in Renal Cell Carcinoma
    Milella, Martina
    Rutigliano, Monica
    Lasorsa, Francesco
    Ferro, Matteo
    Bianchi, Roberto
    Fallara, Giuseppe
    Crocetto, Felice
    Pandolfo, Savio Domenico
    Barone, Biagio
    d'Amati, Antonio
    Spilotros, Marco
    Battaglia, Michele
    Ditonno, Pasquale
    Lucarelli, Giuseppe
    BIOMOLECULES, 2024, 14 (03)
  • [26] Lack of evidence for an immunosuppressive role for MUC1
    Stéphane Paul
    Nadine Bizouarne
    Annick Paul
    Michael R. Price
    Gunnar C. Hansson
    Marie Paule Kieny
    R. Bruce Acres
    Cancer Immunology, Immunotherapy, 1999, 48 : 22 - 28
  • [27] Lack of evidence for an immunosuppressive role for MUC1
    Paul, S
    Bizouarne, N
    Paul, A
    Price, MR
    Hansson, GC
    Kieny, MP
    Acres, RB
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (01) : 22 - 28
  • [28] Role of MUC1 in idiopathic pulmonary fibrosis
    Ballester, Beatriz
    Milara, Javier
    Sanz, Celia
    Gonzalez, Sonia
    Guijarro, Ricardo
    Martinez, Cecilia
    Cortijo, Julio
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [29] Pivotal role of MUC1 glycosylation by cigarette smoke in modulating disruption of airway adherens junctions in vitro
    Zhang, Lili
    Gallup, Marianne
    Zlock, Lorna
    Chen, Yu Ting Feeling
    Finkbeiner, Walter E.
    McNamara, Nancy A.
    JOURNAL OF PATHOLOGY, 2014, 234 (01): : 60 - 73
  • [30] Role of MUC1 in pancreatic cancer.
    Basu, Gargi D.
    Tinder, Teresa L.
    Bradley, Judy M.
    Gendler, Sandra J.
    De Petris, Giovanni
    Mukherjee, Pinku
    CANCER RESEARCH, 2006, 66 (08)